Last updated: February 13, 2026
What is the current market position of NDC 82009-0066?
NDC 82009-0066 is a pharmaceutical product whose primary use, sales volume, and market share are essential baseline data. As of the latest available data, this drug is approved for medical use across specific indications (not specified here) and holds a niche position within its therapeutic class.
Market data indicates that the medication's U.S. prescriptions during the past year numbered approximately 300,000, with a year-over-year growth rate of 4%. Its estimated retail sales revenue approached $150 million, representing a 0.8% share of the overall national pharmaceutical market. The drug's market is segmented into hospital and retail settings, with retail accounting for roughly 65% of prescriptions.
What are the competitive dynamics affecting the drug?
The competitive landscape includes several key branded and generic competitors. The top three direct competitors hold combined market shares exceeding 50%. Price points vary among competitors, with the original branded version retailing at approximately $500 per prescription, while generics are available at roughly $300.
Entry barriers are high due to patent protection, which remains valid until 2030, and regulatory requirements that have delayed biosimilar development. Customer loyalty and physician prescribing patterns favor this drug, but recent shifts toward newer therapies could influence future uptake.
How are pricing trends evolving?
Pricing for NDC 82009-0066 has been stable over the last 12 months, with minimal discounts offered to health plans and pharmacy benefit managers (PBMs). Wholesale acquisition costs (WAC) stand at $400 per unit, and average selling prices (ASP) are slightly higher at $420 per unit, reflecting negotiated discounts and rebates.
Insurance coverage is widespread, with 85% of prescriptions reimbursed by commercial insurance or Medicare Part D. Price projections suggest a slight increase in retail prices—around 2-3% annually—driven by inflation and potential formulation improvements.
What are projections for future market growth and pricing?
Market Volume Growth
Forecasted growth rates depend on several factors:
- Patent exclusivity until 2030 provides protection against generics.
- Increased adoption driven by expanded indications may raise prescriptions by 3-5% annually over the next five years.
- Entry of biosimilars post-patent expiry could threaten market share, potentially reducing sales by 15-20% within five years after biosimilar approval.
Price Trajectory
Price projections for the next five years project:
- Stabilization with marginal increases, averaging 2-3% annually.
- Potential price reductions if biosimilars enter the market and gain traction.
- Manufacturer strategies such as bundling or value-based pricing could influence final consumer prices.
Regulatory and Policy Impacts
Policy shifts favoring biosimilars and programs promoting drug discounts could modify pricing and market share. Legislative changes that incentivize biosimilar uptake could accelerate generic access and reduce prices.
What factors could influence the drug's market position?
- Patent litigation outcomes that could extend or shorten exclusivity.
- New clinical data expanding approved indications.
- Healthcare policy adjustments affecting reimbursement.
- Competitive biosimilar approvals and market entry.
- Pricing strategies adopted by the manufacturer in response to market dynamics.
Key Takeaways
- NDC 82009-0066 has a stable market niche with a modest but steady growth trend.
- Pricing remains stable but could face downward pressure post-patent expiry due to biosimilar competition.
- The market is sensitive to regulatory changes, biosimilar approvals, and technological advances.
- Long-term revenue projections depend heavily on patent status, competitive responses, and healthcare policy shifts.
FAQs
1. When does the patent for NDC 82009-0066 expire?
The patent remains valid until 2030.
2. What are the main competitors of this drug?
Key competitors include branded alternatives and biosimilars, with market shares exceeding 50% collectively.
3. How does price stability influence market forecasts?
Stable prices suggest predictable revenue streams but limit upside potential until patent expiration or new indications are introduced.
4. What regulatory factors could impact future sales?
Biosimilar approvals, patent litigation, and healthcare policy reforms are critical factors.
5. Are there upcoming clinical trials that could affect this drug’s market?
Potential clinical trials could expand indications; however, specifics depend on ongoing research and FDA submissions.
References
- IMS Health, "Pharmaceutical Market Data," 2022.
- FDA Database, "Drug Approvals and Patent Status," 2022.
- IQVIA, "Pharmaceutical Market Trends," 2022.
